Latest Announcements

BSE & NSE corporate filings with AI summaries

BSEAGM/EGMResults2d ago

Godfrey Phillips India Ltd

89th Annual General Meeting of the Company to be held on Monday, 24th August 2026 at 2.30 P.M. through VC/OAVM.

Godfrey Phillips India Ltd announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company's board of directors approved the results and fixed August 11, 2026, as the record date for the payment of the final dividend for the financial year 2025-26. The 89th Annual General Meeting will be held on August 24, 2026, through video conferencing.

Read more →📎 1 attachment
NSENews VerificationRegulatory2d ago

Bank of Baroda

News Verification

The Bombay Stock Exchange (BSE) has sought clarification from Bank of Baroda regarding a news report that the bank's data was leaked on the dark web.

NSEStatement of deviation(s) or variation(s) under Reg. 32Results2d ago

Emkay Global Financial Services Limited

Statement of deviation(s) or variation(s) under Reg. 32

Emkay Global Financial Services Limited has informed the Exchange about the outcome of its Board Meeting held on 27th July, 2026, where the Board approved the unaudited standalone and consolidated financial results for the quarter ended 30th June, 2026, along with the Limited Review Report issued by the Statutory Auditor.

Read more →📎 1 attachment
BSEAGM/EGMMgmt Change2d ago

NESCO Ltd

Proceedings of 67th Annual General Meeting

NESCO Ltd held its 67th Annual General Meeting (AGM) on July 27, 2026, through video conference, where the company's financial statements, dividend declaration, and director appointments were discussed and voted on.

Read more →📎 1 attachment
BSECompany UpdateResults2d ago

Senores Pharmaceuticals Ltd

Senores Pharmaceuticals Limited has informed the Exchange regarding submission of statement of deviation or variation in utilisation of funds of public issue for quarter ended June 30, 2026

Senores Pharmaceuticals Ltd has submitted a statement of deviation or variation in utilisation of funds of public issue for the quarter ended June 30, 2026, indicating no deviation or variation in the utilization of proceeds of IPO.

Read more →📎 1 attachment
NSEGeneral UpdatesResults2d ago

Emkay Global Financial Services Limited

General Updates

Emkay Global Financial Services Limited has informed the Exchange about the outcome of its Board Meeting for the quarter ended 30th June, 2026, where the Board approved the unaudited standalone and consolidated financial results for the quarter.

Read more →📎 1 attachment
BSEOthersResults2d ago

Mysore Petro Chemicals Ltd-$

Corrigendum to Annual Report for the FY 2025-26

Mysore Petro Chemicals Ltd has issued a corrigendum to its Annual Report for FY 2025-26, correcting typographical errors in the report. The corrections include changes to page numbers and figures. The revised report is being disseminated electronically to shareholders. The company has also announced its 56th Annual General Meeting, scheduled for August 11, 2026, to consider the audited financial statements, dividend declaration, and director appointment.

Read more →📎 1 attachment
BSECompany Updatecredit_rating2d ago

Nahar Capital and Financial Services Ltd

Intimation of Credit Rating is enclosed.

Nahar Capital and Financial Services Ltd has announced that ICRA Limited has reaffirmed the credit rating for the company's proposed Short Term Debt/Commercial Paper Programme at '[ICRA] A1+' (pronounced as ICRA A one plus), indicating a very strong degree of safety regarding timely payment of financial obligations and the lowest credit risk.

Read more →📎 1 attachment
NSEStatement of deviation(s) or variation(s) under Reg. 32Results2d ago

Senores Pharmaceuticals Limited

Statement of deviation(s) or variation(s) under Reg. 32

Senores Pharmaceuticals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 for the quarter ended June 30, 2026. The company has confirmed that there has been no deviation(s) or variation(s) in the utilization of proceeds of IPO for the mentioned period. However, there is a delay in the going concern principle for investment in one of our subsidiaries, Havix, to fund deployment of capital of funds expenditure under requirements for setting up a manufacturing company facility for the production of sterile injections in our Atlanta facility.

Read more →📎 1 attachment
NSEShareholders meetingResults2d ago

Pokarna Limited

Shareholders meeting

Pokarna Limited has submitted the Exchange a copy of the Scrutinizer's report of the Annual General Meeting held on July 27, 2026, and informed the Exchange regarding voting results.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults2d ago

Gravita India Limited

Investor Presentation

Gravita India Limited has informed the Exchange about Investor Presentation, highlighting its growth trajectory in Q1FY27 with YoY growth of 42% in revenue, 29% in EBITDA, and 14% in PAT. The Company expanded its Phagi lead recycling capacity and received the London Metal Exchange (LME) Brand Listing for its lead metal.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults2d ago

Gravita India Ltd

Please find enclosed investor presentation of the Company for the Quarter ended 30th June 2026

Gravita India Ltd submitted an investor presentation for the quarter ended 30th June 2026, highlighting a 42% YoY growth in revenue, 29% in EBITDA, and 14% in PAT. The company expanded its lead recycling capacity and received the London Metal Exchange (LME) Brand Listing for its lead metal. ICRA Limited upgraded the company's credit rating.

Read more →📎 1 attachment
← PreviousPage 259 of 1640Next →